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Abstract
A simple and efficient method for the preparation of pyrimidine 2′-O-
hydroxyethoxymethylribonucleosides and 2′-O-hydmxypropoxymethylribonucleosides has been
developed. These modified nucleosides were incorporated into oligoribonucleotides, which were
shown to form stable RNA/RNA duplexes. The effect of 2′-O-modification in the antisense and sense
strands of small interference RNA was evaluated in multi-drug resistant NIH 3T3 cells.
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Modified oligonucleotides (ONs) are widely used in molecular biology and medicinal
chemistry. Antisense agents are valuable tools to inhibit the expression of a target gene in a
sequence specific manner, and may be used for functional genomics, target validation and
therapeutic purposes.[1] Research in this field increased in impact by the discovery of RNA
interference.[2,3]
Numerous attempts have been made to improve the properties of natural ONs. It is believed
that the 2′-carbohydrate modifications are the most universal and promising.[4–6] A typical
strategy for the preparation of such ONs is the synthesis of modified nucleoside followed by
conversion to the corresponding phosphoramidite suitable for automated ON synthesis. Most
of these modifications were achieved via alkylation reactions of partially protected
ribonucleosides. The heterocyclic bases should be protected in order to avoid their alkylation.
For each nucleoside the specific blocking groups are used,[7] which in most cases are not
compatible with standard automated ON synthesis. Very recently for the preparation of 2′-O-
modified nucleosides we have developed another type of chemistry based on O-glycosylation
reactions, which have several important advantages, such as increased yields and
simplification.[8,9] A simple and effective method for the preparation of 2′-O-(β-D-
ribofuranosyl)nucleosides starting from readily available 3′,5′-O-blocked N-
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acylribonucleosides and 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose preactivated with tin
tetrachloride in 1,2-dichloroethane at 0°C, has been recently developed.[10–12]
RESULTS AND DISCUSSION
Here we present our recent results on the preparation of 2′-O-
hydroxyalkoxymethylribonucleosides and their incorporation into oligoribonucleotides.[13]
This scheme is nearly the same as for the preparation of disaccharide nucleosides and their
incorporation into ONs.[14] The starting compounds 1(n = 1, 2)[15] were easily prepared from
1,3-dioxolane and 1,3-dioxalane, respectively, and were condensed with 3′,5′-O-blocked
ribonucleosides 2 (B = Ura, CytBz) in the presence of tin tetrachloride in 1,2-dichloroethane
at −12°C for 20 minutes (Figure 1). The yields (85–87%) of products 3 were even higher than
in the case of above preparation of above mentioned disaccharide nucleosides.[10] The silyl
group was cleaved to yield partially protected 4 and subsequent deblocking with ammonia in
methanol gave free 2′-O-substituted nucleosides 5 in high overall yield. Nucleosides 4 were
converted using standard procedures to the corresponding monomethoxytrityl derivatives 6
and their phosphoramidites 7. With these phosphoramidites, several oligoribonucleotides with
one or more modifications were assembled. It was shown that modified ONs form stable RNA/
RNA duplexes, with about 0.5°C destabilization per modification.
In addition several siRNAs comprising one or more of the new modifications have been
prepared and are currently under evaluation. The effects of 2′-O-modification in the antisense
and sense strands of small interfering RNA targeting the MDR1 gene was evaluated in multi-
drug resistant NIH 3T3 cells using previously described techniques.[16] Standard siRNA or
siRNAs with 2′-O-hydroxyalkoxymethylribonucleosides in the sense strand effectively
inhibited P-glycoprotein expression, whereas modifications in the antisense strand were not
tolerated.
CONCLUSIONS
The general method for the preparation of 2′-O-β-D-ribofuranosylnucleosides was found to be
applicable for the synthesis of pyrimidine 2′-O-hydroxyalkoxymethylribonucleosides. The 2′-
O-substitutent was found to be stable during oligonucleotide synthesis. Additional work on the
preparation of other 2′-O-functionalized nucleosides and oligonucleotides bearing amino
groups is in progress and will be published shortly.
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B = Ura, CytBz; B′ = Ura, Cyt; n = 1,2. a) SnCl4/ClCH2CH2Cl,−12°C; b). Bu4NF/THF; c)
NH3/MeOH, d) MMTrCl/Py;e) ClP(Nlpr2)(OCH2CH2CN);f) oligoribonucleotide syethesis.
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